NCT06349265View on ClinicalTrials.gov

Ultrasound-Guided 5% Dextrose Injection for Carpal Tunnel Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

October 2, 2023

Primary Completion Date

February 2, 2024

Study Completion Date

March 2, 2024

Conditions
Carpal Tunnel Syndrome
Interventions
DRUG

Carpal Tunnel Hydrodissection with %5 dextrose in water injection

Under the inplane ulnar approach, 3ml injectate was injected to hydrodissect the median nerve from the flexor retinaculum, and the residual 2ml injectate was then injected to hydrodissect the inferior median nerve away from the flexor tendons.

Trial Locations (1)

37150

Gamze Gül Güleç, Kastamonu

All Listed Sponsors
lead

Kastamonu University

OTHER

NCT06349265 - Ultrasound-Guided 5% Dextrose Injection for Carpal Tunnel Syndrome | Biotech Hunter | Biotech Hunter